136 related articles for article (PubMed ID: 368681)
1. [Trithiozine and peptic ulcer. Double-blind clinical study].
Catalano F; Brogna A; Blasi A
Minerva Dietol Gastroenterol; 1978; 24(3):197-201. PubMed ID: 368681
[No Abstract] [Full Text] [Related]
2. [Treatment of gastroduodenitis. Controlled evaluation of trithiozine].
Forni E; Pinchetti R; Tinozzi S
Minerva Dietol Gastroenterol; 1978; 24(3):237-46. PubMed ID: 368682
[No Abstract] [Full Text] [Related]
3. Cross-over clinical comparison between anti-secretory activity of propantheline bromide and trithiozine (I.S.F. 2001).
Corinaldesi R; Luchetta L; Ricci P; Guidoboni R; Casadio R; Fabbri R; Barbara L
Panminerva Med; 1977; 19(5):339-44. PubMed ID: 341044
[No Abstract] [Full Text] [Related]
4. [Trithiozine in peptic ulcer. Controlled clinical study].
Herrerias Gutierrez JM; Garrido Peralta M
Clin Ter; 1979 Feb; 88(4):363-9. PubMed ID: 378517
[No Abstract] [Full Text] [Related]
5. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
Tripathi BM; Misra NP; Dube S
J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
[No Abstract] [Full Text] [Related]
6. [Action of trithiozine (ISF 2001) on nocturnal gastric secretion. Double blind cross-over study].
Pooro GB; Ferrara A; Lazzaroni M; Petrillo M; Guidoboni R
Minerva Gastroenterol; 1977; 23(1):21-6. PubMed ID: 321986
[No Abstract] [Full Text] [Related]
7. Trithiozine: a new agent for peptic ulcer and hypersecretory disorders.
Pellegrini R; Albrici A
Farmaco Prat; 1979 Mar; 34(3):138-40. PubMed ID: 456549
[No Abstract] [Full Text] [Related]
8. Clinical effects of trithiozine, a newer gastric anti-secretory agent.
Pellegrini R
J Int Med Res; 1979; 7(5):452-8. PubMed ID: 387498
[TBL] [Abstract][Full Text] [Related]
9. [A controlled trial of prevention of recurrence of gastroduodenal ulcers with proxybarbital].
Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):364-6. PubMed ID: 2696937
[TBL] [Abstract][Full Text] [Related]
10. [Degree of objectivity in the assessment of the effect of antiulcer agents].
Geller LI
Sov Med; 1991; (6):58-60. PubMed ID: 1887308
[No Abstract] [Full Text] [Related]
11. [Clinical trial of Alcid V in peptic ulcer therapy].
Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K
Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375
[No Abstract] [Full Text] [Related]
12. Effects of intravenous trithiozine (I.S.F. 2001) on gastric secretion in man.
Corinaldesi R; Luchetta L; Ricci P; Guidoboni R; Casadio R; Fabbri R; Barbara L
Panminerva Med; 1977; 19(5):333-8. PubMed ID: 600545
[No Abstract] [Full Text] [Related]
13. [Effect of azafen on an experimental model of peptic ulcer].
Kanishchev PA; Pereviazka AV
Farmakol Toksikol; 1988; 51(1):37. PubMed ID: 3360104
[No Abstract] [Full Text] [Related]
14. [Sucralfate versus placebo in duodenal ulcer. A clinical endoscopic double-blind controlled study].
Elsborg L; Boysen K; Bruusgaard A; Reinicke V
Ugeskr Laeger; 1983 May; 145(19):1440-2. PubMed ID: 6349070
[No Abstract] [Full Text] [Related]
15. [Some problems concerning the evaluation of modern contra-ulcerous drugs. Comparison of four medicaments suppressing gastric acidity (author's transl)].
Gibinski K
Cesk Gastroenterol Vyz; 1981 May; 35(3):118-22. PubMed ID: 6269763
[No Abstract] [Full Text] [Related]
16. [Inhibiting action of trithiozine (ISF 2001) and of propantheline on gastric secretion in humans. Double-blind cross-over studies].
Bianchi Porro G; Petrillo M; Ferrara A; Abbondati G
Minerva Gastroenterol; 1976; 22(2):149-52. PubMed ID: 787828
[No Abstract] [Full Text] [Related]
17. [Randomized double-blind placebo-controlled study of drugs with anti-ulcer action and their use in associated pathology].
Ivashkin VT; Minasian GA
Ter Arkh; 1988; 60(1):78-83. PubMed ID: 3129806
[TBL] [Abstract][Full Text] [Related]
18. Uncontrolled factors in controlled trials of peptic ulcer.
Bonfils S; Baron JH; Blum A
Dig Dis Sci; 1984 Sep; 29(9):858-61. PubMed ID: 6468216
[No Abstract] [Full Text] [Related]
19. A double blind evaluation of the effect of tri-potassium di-citrato bismuthate in peptic ulcer.
Poulantzas J; Polymeropoulos PS; Papasomatious A
Br J Clin Pract; 1978 May; 32(5):147-8. PubMed ID: 352384
[No Abstract] [Full Text] [Related]
20. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
